tiprankstipranks
Advertisement
Advertisement

AU:RCE Stock Latest News

Recce Wins Brazilian Patent for Broad-Spectrum Anti-Infective Portfolio
Company AnnouncementsRecce Wins Brazilian Patent for Broad-Spectrum Anti-Infective Portfolio
18d ago
Recce Pharmaceuticals Issues Webinar Disclaimer on Investor Information and U.S. Offer Restrictions
PremiumCompany Announcements
Recce Pharmaceuticals Issues Webinar Disclaimer on Investor Information and U.S. Offer Restrictions
23d ago
Recce Pharmaceuticals Schedules Investor Webinar to Highlight Key Anti-Infective Programs
PremiumCompany Announcements
Recce Pharmaceuticals Schedules Investor Webinar to Highlight Key Anti-Infective Programs
25d ago
Recce Pharmaceuticals Deepens R&D-Driven Loss as Anti-Infective Programs Advance
PremiumCompany Announcements
Recce Pharmaceuticals Deepens R&D-Driven Loss as Anti-Infective Programs Advance
1M ago
Recce Pharmaceuticals Director Options Lapse Following Scheduled Expiry
PremiumCompany Announcements
Recce Pharmaceuticals Director Options Lapse Following Scheduled Expiry
2M ago
Recce Pharmaceuticals Options Lapse, Simplifying Capital Structure
PremiumCompany AnnouncementsRecce Pharmaceuticals Options Lapse, Simplifying Capital Structure
2M ago
Recce Pharmaceuticals Deepens U.S. Army Ties With New Burn Wound Gel Study
Premium
Company Announcements
Recce Pharmaceuticals Deepens U.S. Army Ties With New Burn Wound Gel Study
2M ago
Recce Advances Phase 3 Diabetic Foot Trial and Strengthens Anti-Infective Pipeline
Premium
Company Announcements
Recce Advances Phase 3 Diabetic Foot Trial and Strengthens Anti-Infective Pipeline
2M ago
Recce Pharmaceuticals Secures $5.3m R&D Rebate to Bolster Anti-Infective Pipeline
PremiumCompany Announcements
Recce Pharmaceuticals Secures $5.3m R&D Rebate to Bolster Anti-Infective Pipeline
3M ago
Recce Pharmaceuticals Secures A$85 Million R&D Tax Incentive for Global Anti-Infective Programs
PremiumCompany Announcements
Recce Pharmaceuticals Secures A$85 Million R&D Tax Incentive for Global Anti-Infective Programs
4M ago
Recce Pharmaceuticals Secures Hong Kong Patent for Anti-Infectives
PremiumCompany Announcements
Recce Pharmaceuticals Secures Hong Kong Patent for Anti-Infectives
5M ago
Recce Pharmaceuticals Reports Promising Preclinical Results for Inhaled RECCE® 327
PremiumCompany Announcements
Recce Pharmaceuticals Reports Promising Preclinical Results for Inhaled RECCE® 327
5M ago
Recce Pharmaceuticals Mourns the Loss of Founder Dr. Graham JH Melrose
PremiumCompany AnnouncementsRecce Pharmaceuticals Mourns the Loss of Founder Dr. Graham JH Melrose
5M ago
Recce Pharmaceuticals Ltd 2025 AGM Results Announced
Premium
Company Announcements
Recce Pharmaceuticals Ltd 2025 AGM Results Announced
5M ago
Recce Pharmaceuticals Outlines Future Strategies at 2025 AGM
Premium
Company Announcements
Recce Pharmaceuticals Outlines Future Strategies at 2025 AGM
5M ago
Recce Pharmaceuticals Advances Phase 3 Trial for Diabetic Foot Infections in Indonesia
PremiumCompany Announcements
Recce Pharmaceuticals Advances Phase 3 Trial for Diabetic Foot Infections in Indonesia
5M ago
Recce Pharmaceuticals Announces Director’s Interest Change
PremiumCompany Announcements
Recce Pharmaceuticals Announces Director’s Interest Change
6M ago
Recce Pharmaceuticals Announces Cessation of Securities
PremiumCompany Announcements
Recce Pharmaceuticals Announces Cessation of Securities
6M ago
Recce Pharmaceuticals Completes Selective Buy-Back of Performance Shares
PremiumCompany Announcements
Recce Pharmaceuticals Completes Selective Buy-Back of Performance Shares
6M ago
Recce Pharmaceuticals Updates Buy-Back Date
PremiumCompany AnnouncementsRecce Pharmaceuticals Updates Buy-Back Date
6M ago
Recce Pharmaceuticals Announces 2025 Annual General Meeting
Premium
Company Announcements
Recce Pharmaceuticals Announces 2025 Annual General Meeting
6M ago
Recce Pharmaceuticals Advances Phase 3 Trial for Diabetic Foot Infections in Indonesia
Premium
Company Announcements
Recce Pharmaceuticals Advances Phase 3 Trial for Diabetic Foot Infections in Indonesia
7M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >